Evidence map›Paper›PMID 32471217›Full record

ReviewNutrients2020

Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?

Dominika Kuran, Anna Pogorzelska, Katarzyna Wiktorska

Abstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dominika KuranDepartment of Pharmacology, National Medicines Institute, 00-725 Warsaw, Poland.ORCID 0000-0003-0502-0898
Anna PogorzelskaDepartment of Drug Biotechnology and Bioinformatics, National Medicines Institute, 00-725 Warsaw, Poland.ORCID 0000-0002-4006-2682
Katarzyna WiktorskaDepartment of Drug Biotechnology and Bioinformatics, National Medicines Institute, 00-725 Warsaw, Poland.ORCID 0000-0002-2731-9535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most prevalent type of cancer among women worldwide. There are several recommended methods of breast cancer prevention, including chemoprevention. There are several approved drugs used to prevent breast cancer occurrence or recurrence and metastasizing. There are also a number of new substances undergoing clinical trials and at the stage of initial study. Studies suggest that dietary factors play a crucial role in breast cancer etiology. Epidemiological studies indicate that in particular vegetables from the

Indexed as

AnimalsAntineoplastic AgentsBrassicaceaeBreast NeoplasmsChemopreventionFemaleHumansIsothiocyanatesNeoplasm Recurrence, LocalSignal TransductionSulfoxidesVegetablesAntineoplastic AgentsIsothiocyanatessulforaphaneSulfoxidesanticancer activitybreast cancerchemopreventionisothiocyanatessulforaphane

Identifiers

PMID32471217
PMCPMC7352481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.